The FY21 KCRP Program Announcements and General Application Instructions for Kidney Cancer Care Research Program can be found here.
Thermo Fisher Scientific has opened submissions for the Oncomine Clinical Research Grant program to support clinical research projects in oncology.
The Pancreatic Cancer Action Network has added another treatment arm by biopharmaceutical company FibroGen Inc. to its clinical trial platform, Precision Promise.
Data from three pivotal phase III studies—CLL14, MURANO and VIALE-A—of Venclexta (venetoclax) support the primary analysis of Venclexta in chronic lymphocytic leukemia and the possibility of tailoring treatment approaches based on genetic risk factors.
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody.
Pairing sky-mapping algorithms with advanced immunofluorescence imaging of cancer biopsies, researchers at The Mark Foundation Center for Advanced Genomics and Imaging at Johns Hopkins University and the Bloomberg-Kimmel Institute for Cancer Immunotherapy developed a robust platform to guide immunotherapy by predicting which cancers will respond to specific therapies targeting the immune system.
Salk researchers, led by Susan Kaech, have found that the tumor microenvironment contains an abundance of oxidized fat molecules, which, when ingested by the killer T cells, suppresses their ability to kill cancer cells.
FDA has approved Ayvakit (avapritinib) for adult patients with advanced systemic mastocytosis, including patients with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia.
Miruna Sasu spent more than 20 years as a digital health and innovation expert at life sciences companies—then came a realization
Caryn Lerman has stepped in as president of the Association of American Cancer Institutes. Lerman, director of USC Norris Comprehensive Cancer Center and associate dean for cancer programs at the University of Southern California, was the AACI president-elect.
